Evidence map›Paper›PMID 29343557›Full record

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2018

Kris Ann P Schultz, Gretchen M Williams, Junne Kamihara, Douglas R Stewart, Anne K Harris, Andrew J Bauer, Joyce Turner, Rachana Shah, Katherine Schneider, Kami Wolfe Schneider and 10 more

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 179 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed, 4 pooled it
36.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00565903 completednot on this map

Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome

TypeobservationalSponsorAshley HillRan2005 to 2022Enrolled1,247ConditionsPleuropulmonary Blastoma, Cystic Nephroma, Sertoli-Leydig Cell Tumor of Ovary, Medulloepithelioma
NCT03382158 recruitingnot on this map

International Pleuropulmonary Blastoma/DICER1 Registry (for PPB, DICER1 and Associated Conditions)

Typeobservational_patient_registrySponsorChildren's Hospitals and Clinics of MinnesotaRan2016 to 2035Enrolled3,400ConditionsPleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor, DICER1 Syndrome, Cystic Nephroma
3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 4 syntheses or guidelines pooled it, 362 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Inherited cancer syndromes in adult oncology: a referral guide based on malignant tumor and polyp features.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. MosaicFrontiers in oncology · 2026
    Article
  19. Review
  20. Article

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 13 institutions in 4 countries.

Kris Ann P SchultzInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota. krisann.schultz@childrensmn.org.
Gretchen M WilliamsInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota.
Junne KamiharaPediatric Oncology, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Solid Tumor Programs, Boston, Massachusetts.
Douglas R StewartClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Anne K HarrisInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota.
Andrew J BauerDivision of Endocrinology and Diabetes, Pediatric Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Joyce TurnerCancer Genetic Counseling Program, George Washington University, Children's National Medical Center, Washington, D.C.
Rachana ShahDivision of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Katherine SchneiderDana-Farber Cancer Institute, Center for Cancer Genetics and Prevention, Boston, Massachusetts.
Kami Wolfe SchneiderHematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, Colorado.
Ann Garrity CarrWestat, Rockville, Maryland.
Laura A HarneyWestat, Rockville, Maryland.
Shari BaldingerVirginia Piper Cancer Institute, Allina Health, Minneapolis, Minnesota.
A Lindsay FrazierPediatric Oncology, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Solid Tumor Programs, Boston, Massachusetts.
Daniel OrbachSIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris, France.
Dominik T SchneiderClinic of Pediatrics, Municipal Hospital Dortmund, Dortmund, Germany.
David MalkinDivision of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Louis P DehnerDivision of Anatomic Pathology, Lauren V. Ackerman Laboratory of Surgical Pathology, Barnes-Jewish and St. Louis Children's Hospitals, Washington University Medical Center, St. Louis, Missouri.
Yoav H MessingerInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota.
D Ashley HillDepartment of Pathology, Center for Cancer and Immunology Research, Children's National Medical Center, Washington D.C.
Children’s Minnesota - St. Paul Hospital · USChildren's Hospital Colorado · USChildren's National · USDana-Farber Cancer Institute · USWestat (United States) · USAllina Health · USChildren's Hospital of Philadelphia · USCincinnati Children's Hospital Medical Center · USInstitut Curie · FRKlinikum Dortmund · DENational Cancer Institute · USSt. Louis Children's Hospital · USUniversity of Toronto · CA

Funding

Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
DICER1 and the Pleuropulmonary Blastoma Family Cancer SyndromeR01CA143167 · NCI · CHILDREN'S RESEARCH INSTITUTE · PI HILL, DANA ASHLEY · 2010 to 2020
$3.7M
NCI NIH HHS R01 CA143167
6 · The paper itself

Abstract

Pathogenic germline

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAlgorithmsDEAD-box RNA HelicasesDisease ManagementFemaleGenetic TestingGenotypeGlobal HealthHumansInheritance PatternsMass ScreeningMutationNeoplastic Syndromes, HereditaryPenetrancePrenatal DiagnosisDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease III

Identifiers

PMID29343557
PMCPMC6260592
OpenAlexW2792841925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.